Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients. [electronic resource]
Producer: 20171016Description: 1034-1043 p. digitalISSN:- 1522-9645
- Acute Coronary Syndrome -- mortality
- Analysis of Variance
- Aspirin -- administration & dosage
- Blood Vessel Prosthesis Implantation -- methods
- Clopidogrel
- Coronary Artery Disease -- mortality
- Death, Sudden, Cardiac -- epidemiology
- Drug Administration Schedule
- Drug Therapy, Combination
- Drug-Eluting Stents
- Female
- Graft Occlusion, Vascular -- etiology
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- mortality
- Myocardial Revascularization -- methods
- Platelet Aggregation Inhibitors -- administration & dosage
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Randomized Controlled Trials as Topic
- Risk Assessment
- Stroke -- mortality
- Ticlopidine -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review
There are no comments on this title.
Log in to your account to post a comment.